Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
      • Research Guidelines
        • Minimum Information About Microarray Data Experiments (MIAME)
      • Abstract
      • Acknowledgments
      • Clinical Implications (Only by invitation)
      • Conflict(s) of Interest/Disclosure(s) Statement
      • Figure Legends
      • Figures
      • Novelty and Significance: 1) What Is New, 2) What Is Relevant?
      • References
      • Sources of Funding
      • Tables
      • Text
      • Title Page
      • Online/Data Supplement
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
      • Change of Authorship Form
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Hypertension

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Poster Session II

Abstract 396: Enhanced VEGF and ETS-1 Recruitment by T Reg- Heme Oxygenase- 1 Module Increases Blood Flow in Post-infarction Myocardium in SCID Mice

Robert Touchon, Ellen Thompson, Komal Sodhi, Gaia Favero, Rita Rezzani, Rodella Luigi Fabrizio, Nader G Abraham, Joseph Shapiro, Larry Dial
Hypertension. 2013;62:A396
Robert Touchon
Dept of Cardiology, Marshall Univ, Joan C. Edwards Sch of Medicine, Huntington, WV
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ellen Thompson
Dept of Cardiology, Marshall Univ, Joan C. Edwards Sch of Medicine, Huntington, WV
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Komal Sodhi
Dept of Surgery, Marshall Univ, Joan C. Edwards Sch of Medicine, Huntington, WV
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gaia Favero
Dept of Clinical and Experimental Sciences, Div of Anatomy and Physiopathology, Univ of Brescia, Brescia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rita Rezzani
Dept of Clinical and Experimental Sciences, Div of Anatomy and Physiopathology, Univ of Brescia, Brescia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rodella Luigi Fabrizio
Dept of Clinical and Experimental Sciences, Div of Anatomy and Physiopathology, Univ of Brescia, Brescia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nader G Abraham
Dept of Medicine, Marshall Univ, Joan C. Edwards Sch of Medicine, Huntington, WV
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Shapiro
Dept of Medicine, Marshall Univ, Joan C. Edwards Sch of Medicine, Huntington, WV
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Larry Dial
Dept of Medicine, Marshall Univ, Joan C. Edwards Sch of Medicine, Huntington, WV
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics

Jump to

  • Article
  • Info & Metrics
  • eLetters
Loading

Abstract

Introduction: Post-infarction cardiomyopathy has been ascribed to chronic inflammation, increased oxidative stress and insufficient angiogenesis. T lymphocyte mediated immune response plays an important role in post-infarct cardiac remodeling. T regulatory lymphocytes (Treg) are a subpopulation of T helper lymphocytes with a regulatory and immunosuppressive role. Heme oxygenase (HO)-1 induction improves heart function after ischemic damage by its anti-oxidative effect. To assess the role of the HO-1 mediated increased levels of T-reg lymphocytes in immunosuppressed mice in a model of post-infarcted heart failure.

Methods: We compared the effect of HO-1 induction on post-infarction myocardium induced by left anterior coronary artery ligation in T-lymphocyte immunosuppressed mice (BALB SCID). Mice were divided into 4 groups: sham, myocardial infarction (MI), MI treated with the HO-1 inducer cobalt protoporphyrin (CoPP) with and without the HO activity inhibitor stannous mesoporphyrin (SnMP). Thirty days after surgery all mice underwent echocardiography, immunohistochemistry and an assessment of T-lymphocyte subpopulations (Treg cells) via fluorescence activated cell sorting (FACS).

Results: Mice with MI had increased levels of inflammatory cytokines (p<0.05) and lower capillary density (SCID: 1.2±0.7% vs control: 4.3±0.9%; p<0.01). Left ventricle end diastolic area (EDA) was reduced in CoPP treated compared to the MI group (EDA: MI: 0.22 ±0.02 cm; MI+CoPP: 0.17±0.03 cm; p<0.01). In CoPP treated SCID mice the T-reg subpopulation measured by FACS analysis (20±3% vs 5±3%; p<0.01) and immunohistochemistry (p<0.02) was significantly increased as compared to the MI group. Increased expression of the angiogenic markers VEGF, FGF and ETS-1 (p<0.02) was found in CoPP treated animals as compared to MI animals. These beneficial effects were reversed by SnMP.

Conclusion: Upregulation of HO-1 increases T regulatory cells, reverses dysfunctional remodeling and enhances angiogenesis and peri-infarct survival in the post-infarction myocardium in immunosuppressed mice. Targeted enhancement of T-reg cells via HO-1 induction suggests adjuvant avenues for reducing morbidity and mortality in patients with post-MI heart failure.

  • heme oxygenase
  • Myocardium
  • Blood Flow
  • © 2013 by American Heart Association, Inc.
Back to top
Previous Article

This Issue

Hypertension
September 2013, Volume 62, Issue Suppl 1
  • Table of Contents
Previous Article

Jump to

  • Article
  • Info & Metrics

Article Tools

  • Citation Tools
    Abstract 396: Enhanced VEGF and ETS-1 Recruitment by T Reg- Heme Oxygenase- 1 Module Increases Blood Flow in Post-infarction Myocardium in SCID Mice
    Robert Touchon, Ellen Thompson, Komal Sodhi, Gaia Favero, Rita Rezzani, Rodella Luigi Fabrizio, Nader G Abraham, Joseph Shapiro and Larry Dial
    Hypertension. 2013;62:A396, originally published October 14, 2015

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Hypertension.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Abstract 396: Enhanced VEGF and ETS-1 Recruitment by T Reg- Heme Oxygenase- 1 Module Increases Blood Flow in Post-infarction Myocardium in SCID Mice
    (Your Name) has sent you a message from Hypertension
    (Your Name) thought you would like to see the Hypertension web site.
  • Share on Social Media
    Abstract 396: Enhanced VEGF and ETS-1 Recruitment by T Reg- Heme Oxygenase- 1 Module Increases Blood Flow in Post-infarction Myocardium in SCID Mice
    Robert Touchon, Ellen Thompson, Komal Sodhi, Gaia Favero, Rita Rezzani, Rodella Luigi Fabrizio, Nader G Abraham, Joseph Shapiro and Larry Dial
    Hypertension. 2013;62:A396, originally published October 14, 2015
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Hypertension

  • About Hypertension
  • Instructions for Authors
  • AHA CME
  • Guidelines and Statements
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
7272 Greenville Ave.
Dallas, TX 75231
email: hypertension@heart.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured